Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ototoxicity 1 Neoplasms 1 Myelodysplastic Syndromes 1 Hearing Loss 1

Interventions

Cyclophosphamide 211 fludarabine phosphate 185 Azacitidine 160 fludarabine 144 Busulfan 140 Tacrolimus 120 Mycophenolic Acid 112 Cytarabine 111 Whole-Body Irradiation 107 Peripheral Blood Stem Cell Transplantation 99 Antilymphocyte Serum 97 Melphalan 91 Filgrastim 87 Cyclosporine 83 Decitabine 82 Methotrexate 79 venetoclax 63 Granulocyte Colony-Stimulating Factor 56 Radiotherapy 49 Stem Cell Transplantation 48 Thiotepa 47 Cord Blood Stem Cell Transplantation 43 Clofarabine 42 thymoglobulin 41 Specimen Handling 35 Etoposide 35 Methylprednisolone 34 Sirolimus 33 Biopsy 30 Injections 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × Genetic Association Studies × Clear all

NCT06886425 2025-03-20

CDA-AML-MDS

Assistance Publique Hopitaux De Marseille

Phase NA Recruiting

Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡